NCT05752812Recruiting
The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer
The HELPP Score: A Pretreatment Prognostic Score to Predict Survival and Patterns of Recurrence in Localized Non-Metastatic Pancreatic Cancer - a Multicenter Prospective Validation Study
Source: ClinicalTrials.gov · Last updated 27 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to validate a pretreatment prognostic score (Heidelberg Prognostic Pancreatic Cancer Score - HELPP) in patients with pancreatic ductal adenocarcinoma. The main questions it aims to answer are: * Is the HELPP score able to predict median overall survival in a prospective multi-institutional cohort of patients with pretherapeutic localized non-metastatic pancreatic cancer? * Is the HELPP score able to predict median recurrence-free survival and patterns of recurrence after resection of pancreatic cancer?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 21 Feb 2023
- Start date
- 1 Mar 2023
- Primary completion date
- May 2026
- Lead sponsor
- Medical University of Vienna
- Diseases
- Pancreatic cancer
- NCT number
- NCT05752812
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 1 Mar 2023 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients receiving surgery for peripancreatic cancer
Lab values
- missing mandatory pretreatment laboratory values
Other
- patients with a diagnosis other than pancreatic ductal adenocarcinoma on histopathology
- missing informed consent
- missing mandatory pretreatment clinicopathologic data
- incomplete follow-up records
- follow-up \< 24 months
- pregnancy
Who the study is looking for
- ≥18 years old
- fit to undergo elective pancreatic resection or palliative therapy
- localized non-metastatic pancreatic ductal adenocarcinoma
- informed consent provided
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna Coordinator of this site? Confirm its status | Vienna | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.